Stephen T. Worland - Nov 15, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol
EFTR
Transactions as of
Nov 15, 2022
Transactions value $
$2,832
Form type
4
Date filed
11/16/2022, 05:27 PM
Previous filing
Jun 22, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2.83K +6.05K +2.81% $0.47 221K Nov 15, 2022 Direct F1
holding EFTR Common Stock 562K Nov 15, 2022 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.